Fentadur, Dolfen, Durfenta, Opiodur

Fentadur, Dolfen, Durfenta, Opiodur

Products
Fentadur, Dolfen, Durfenta, Opiodur
Fentadur, Dolfen, Durfenta, Opiodur

Information

A fentanyl transdermal delivery system, developed by Lavipharm's research laboratories in the USA and approved by the FDA, is a small, thin and easy to adhere patch for the management of chronic pain. It is designed to deliver the analgesic substance fentanyl safely and effectively through the skin. This three-day patch provides continuous relief from moderate-to-severe pain, such as that of cancer. It is marketed in five dosage forms, 12μg/h, 25μg/h, 50μg/h, 75μg/h and 100μg/h.
Distribution Areas
Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
Greece
All categories
Finished Dosage FormsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Transdermal PatchesContract ManufacturingDrug Delivery Devices & SystemsProductsServices
Main Categories
Finished Dosage FormsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Drug Delivery Devices & Systems

Log in

See all the content and easy-to-use features by logging in or registering!